* | Page 1 | Search Results | Emerging Technologies and Data Science

1-13 of 13 Search Results for

*

Sort by

Sort Order Select

Journal Articles

Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies

Georgia Mitsa, Livia Florianova, Josiane Lafleur, Adriana Aguilar-Mahecha, Rene P. Zahedi, Sonia V. del Rincon, Mark Basik, Christoph H. Borchers, Gerald Batist

Cancer Research Communications (2025) 5 (1): 138–149.

https://doi.org/10.1158/2767-9764.CRC-24-0287

Published: 23 January 2025

View article titled, Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies

Includes: Supplementary data

Journal Articles

Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy

Jessica L. Root, Poonam N. Desai, Christopher Ly, Bofei Wang, Fatima Zahra Jelloul, Jing Zhou, Sean Mackay, Mansour Alfayez, Jairo Matthews, Sherry Pierce, Patrick K. Reville, Naval Daver, Hussein A. Abbas

Cancer Research Communications (2024) 4 (3): 671–681.

https://doi.org/10.1158/2767-9764.CRC-23-0402

Published: 06 March 2024

View article titled, Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy

Includes: Supplementary data

Journal Articles

Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, Gael Roué, David Valcárcel, Antonieta Molero, Lurdes Zamora, Blanca Xicoy, Laura Palomo, Pamela Acha, Ana Manzanares, Magnus Tobiasson, Eva Hellström-Lindberg, Francesc Solé, Manel Esteller

Cancer Research Communications (2024) 4 (2): 365–377.

https://doi.org/10.1158/2767-9764.CRC-23-0389

Published: 12 February 2024

View article titled, Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Includes: Supplementary data

Journal Articles

A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing

Chien-Wei Wang, Simon D. Weaver, Nicha Boonpattrawong, Naviya Schuster-Little, Manish Patankar, Rebecca J. Whelan

Cancer Research Communications (2024) 4 (1): 253–263.

https://doi.org/10.1158/2767-9764.CRC-23-0327

Published: 31 January 2024

View article titled, A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing

Includes: Supplementary data

Journal Articles

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer

M. Dorso, Payal T. Patel, Aleksandr Pankov, Jacob A. Boyer, Rajesh K. Soni, Isabella S. Del Priore, Omar Hayatt, Amanda Kulick, Connor J. Hagen, Elisa de Stanchina, Melissa R. Junttila, Anneleen Daemen, Lori S. Friedman, Ronald C. Hendrickson, Sarat Chandarlapaty

Cancer Research Communications (2023) 3 (9): 1788–1799.

https://doi.org/10.1158/2767-9764.CRC-23-0310

Published: 07 September 2023

View article titled, A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer

Includes: Supplementary data

Journal Articles

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

Junkai Wang, Alexander B. Saltzman, Eric J. Jaehnig, Jonathan T. Lei, Anna Malovannaya, Matthew V. Holt, Meggie N. Young, Mothaffar F. Rimawi, Foluso O. Ademuyiwa, Meenakshi Anurag, Beom-Jun Kim, Matthew J. Ellis

Cancer Research Communications (2023) 3 (8): 1551–1563.

https://doi.org/10.1158/2767-9764.CRC-22-0501

Published: 15 August 2023

View article titled, Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

Includes: Supplementary data

Journal Articles

Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles

Shilah A. Bonnett, Alyssa B. Rosenbloom, Giang T. Ong, Mark Conner, Aric B.E. Rininger, Daniel Newhouse, Felicia New, Chi Q. Phan, Saskia Ilcisin, Hiromi Sato, John S. Lyssand, Gary Geiss, Joseph M. Beechem

Cancer Research Communications (2023) 3 (5): 763–779.

https://doi.org/10.1158/2767-9764.CRC-22-0396

Published: 03 May 2023

View article titled, Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles

Includes: Supplementary data

Journal Articles

A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases

Vigdis Nygaard, Anne Hansen Ree, Vegar Johansen Dagenborg, Anne-Lise Børresen-Dale, Bjørn Edwin, Åsmund Avdem Fretland, Krzysztof Grzyb, Mads H. Haugen, Gunhild M. Mælandsmo, Kjersti Flatmark

Cancer Research Communications (2023) 3 (2): 235–244.

https://doi.org/10.1158/2767-9764.CRC-22-0295

Published: 09 February 2023

View article titled, A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases

Includes: Supplementary data

Journal Articles

Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

Zhaomei Shi, Binchen Mao, Xiaobo Chen, Piliang Hao, Sheng Guo

Cancer Research Communications (2023) 3 (2): 202–214.

https://doi.org/10.1158/2767-9764.CRC-22-0431

Published: 06 February 2023

View article titled, Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

Includes: Supplementary data

Journal Articles

The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy

Cancer Research Communications (2022) 2 (9): 1075–1088.

https://doi.org/10.1158/2767-9764.CRC-22-0053

Published: 28 September 2022

View article titled, The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy

Includes: Supplementary data

Journal Articles

NetrinG1⁺ Cancer-Associated Fibroblasts Generate Unique Extracellular Vesicles that Support the Survival of Pancreatic Cancer Cells Under Nutritional Stress

Kristopher S. Raghavan, Ralph Francescone, Janusz Franco-Barraza, Jaye C. Gardiner, Débora B. Vendramini-Costa, Tiffany Luong, Narges Pourmandi, Anthony Andren, Alison Kurimchak, Charline Ogier, Paul M. Campbell, James S. Duncan, Costas A. Lyssiotis, Lucia R. Languino, Edna Cukierman

Cancer Research Communications (2022) 2 (9): 1017–1036.

https://doi.org/10.1158/2767-9764.CRC-21-0147

Published: 19 September 2022

View article titled, NetrinG1+ Cancer-Associated Fibroblasts Generate Unique Extracellular Vesicles that Support the Survival of Pancreatic Cancer Cells Under Nutritional Stress

Includes: Supplementary data

Journal Articles

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

Laxmi Silwal-Pandit, Stina M. Stålberg, Henrik J. Johansson, Georgios Mermelekas, Inger Marie B. Lothe, Martina L. Skrede, Astrid Marie Dalsgaard, Daniel J. H. Nebdal, Åslaug Helland, Ole Christian Lingjærde, Knut Jørgen Labori, Bjørn S. Skålhegg, Janne Lehtiö, Elin H. Kure

Cancer Research Communications (2022) 2 (6): 434–446.

https://doi.org/10.1158/2767-9764.CRC-21-0100

Published: 14 June 2022

View article titled, Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

Includes: Supplementary data

Journal Articles

Increased Microtubule Growth Triggered by Microvesicle-mediated Paracrine Signaling is Required for Melanoma Cancer Cell Invasion

Karoline Pudelko, Angela Wieland, Magdalena Hennecke, Markus Räschle, Holger Bastians

Cancer Research Communications (2022) 2 (5): 366–379.

https://doi.org/10.1158/2767-9764.CRC-22-0010

Published: 18 May 2022

View article titled, Increased Microtubule Growth Triggered by Microvesicle-mediated Paracrine Signaling is Required for Melanoma Cancer Cell Invasion

Includes: Multimedia, Supplementary data

NARROW

*

Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies

Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy

Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles

A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases

Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy

NetrinG1⁺ Cancer-Associated Fibroblasts Generate Unique Extracellular Vesicles that Support the Survival of Pancreatic Cancer Cells Under Nutritional Stress

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

Increased Microtubule Growth Triggered by Microvesicle-mediated Paracrine Signaling is Required for Melanoma Cancer Cell Invasion

AACR Journals

*

AACR Journals

This Feature Is Available To Subscribers Only